Mesoridazine (Serentil)

05/01/1971 - "A controlled study of mesoridazine: an effective treatment for schizophrenia."
10/01/1975 - "Plasma levels of mesoridazine and its metabolites and clinical response in acute schizophrenia after a single intramuscular drug dose."
12/01/1981 - "Both controlled and open-label clinical studies have attested to the efficacy of mesoridazine in schizophrenia, as well as certain other psychiatric disorders. "
11/01/1978 - "Treatment with mesoridazine and thioridazine in chronic schizophrenia: II. Potential predictors of drug response."
11/01/1978 - "Treatment with mesoridazine and thioridazine in chronic schizophrenia: I. Assessment of clinical and electrophysiologic responses in refractory hallucinating schizophrenics."

12/01/1981 - "Both controlled and open-label clinical studies have attested to the efficacy of mesoridazine in schizophrenia, as well as certain other psychiatric disorders. "
01/01/1985 - "The intrapatient effect of starting (group A, n = 16), increasing (group B, n = 19), decreasing (group C, n = 23), and discontinuing (group D, n = 34) the phenothiazines (PHZs) thioridazine, chlorpromazine, or mesoridazine on serum phenytoin (PHT), phenobarbital (PB), and primidone (PRI) was studied at a constant antiepileptic drug regimen and between two consecutive steady-state concentration determinations in 92 institutionalized epileptic patients with psychiatric disorders. "

10/01/1991 - "Mesoridazine in neuroleptic-resistant psychoses."
01/16/2015 - "We included all randomised controlled trials (RCTs) that compared oral haloperidol with another oral first-generation antipsychotic drug (with the exception of the low-potency antipsychotics chlorpromazine, chlorprothixene, levopromazine, mesoridazine, perazine, prochlorpromazine, and thioridazine) in schizophrenia and schizophrenia-like psychosis. "

04/01/1977 - "A double-blind study vs. placebo was carried out over a 6-week period in thirty adolescent patients to determine the efficacy and safety of mesoridazine, in the form of 10 mg tablets, in the treatment of symptoms associated with various personality disorders. "
04/01/1977 - "Mesoridazine (Serentil) in personality disorders--a controlled trial in adolescent patients."

10/01/1988 - "Despite the paucity of data on the potential cardiotoxicity associated with mesoridazine overdose, this case demonstrates that malignant arrhythmias and cardiac arrest occur; consequently, these patients probably require constant ECG monitoring."
08/01/1977 - "Successful suicides with thioridazine and mesoridazine: a result of probable cardiotoxicity."